Pod Zegarem Gabinet Psychoterapiisp. z o.o.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-10-06
Share capital
5,000.00 PLN
Registered address
ul. Adama Mickiewicza 32/7, 70-583 Szczecin, Poland
Electronic delivery address
AE:PL-38252-46254-RBDSC-17

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed.

  • 2025not filed
  • 202418/04/2025
  • 202312/03/2024
  • 202202/03/2023
  • 202115/02/2022
  • 202009/03/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 11.30kMedianUSD 91.87kAverageUSD 1.38m
Net profit
This companyUSD -2.05kMedianUSD 2.66kAverageUSD 145.78k
Operating costs
This companyUSD 13.36kMedianUSD 82.81kAverageUSD 1.18m
Assets
This companyUSD 9.14kMedianUSD 39.38kAverageUSD 950.01k

Authorized Representatives

Ewa Lebdowicz Kseniak – President of the Management Board

Manner of representation

In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Wojciech Kseniakage 49
10$270.1220%
Ewa Aleksandra Lebdowicz Kseniakage 49
40$1,080.5080%

Ewa Aleksandra Lebdowicz Kseniak and Wojciech Kseniak hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

FAQ

Last updated: 2026-04-14